| This week's sponsor is Catalent. | | | [Fact Sheet] Biologics Device Assembly & Packaging
Catalent’s biologics packaging operations in the US and Belgium offer state-of-the-art, high-speed, automated equipment, as well as configurable packaging solutions to support both clinical and commercial supply. Learn more about Catalent’s device assembly and packaging capabilities for biologics. |
| Welcome to FierceLifeSci Weekly Digest, your roundup of the biggest and most popular stories from each of our publications. | |
|
Featured Story | | | Wednesday, February 20, 2019 M&A will help the biopharma industry deal with significant new challenges, Morningstar said in a new report, including pressure from lawmakers and payers to lower prices. As companies look for deals to boost their pipelines, oncology, neurology and rare-disease therapeutics will emerge as sought-after assets, the analysts predicted. |
|
|
Top Stories Of The Week Tuesday, February 19, 2019 In a pivotal phase 3 study, Intercept Pharmaceuticals' obeticholic acid met its primary endpoint of improving liver fibrosis without any worsening of nonalcoholic steatohepatitis (NASH) after 18 months of treatment. The company plans to file for approval in the U.S. and Europe by the end of the year. Tuesday, February 19, 2019 A CDMO that has made a habit of snapping up Big Pharma’s discarded manufacturing plants has put a former AstraZeneca plant into bankruptcy. Wednesday, February 20, 2019 Last month, Xencor's partner Novartis returned the rights to a bispecific antibody it had licensed as part of a 2016 deal worth up to $2.41 billion. Now a second asset from that deal, in development for acute myeloid leukemia (AML), has hit a snag in the form of a partial clinical hold from the FDA. Tuesday, February 19, 2019 Activist hedge fund Starboard Value has reportedly hired a proxy solicitor to survey the level of support for the $74 billion Celgene buy. Starboard's interest may be in thwarting the deal by trying to find another buyer for BMS, some analysts have speculated. Monday, February 18, 2019 A Duke lab at the center of a research pact with Sarepta is reporting promising results from a trial of CRISPR gene editing in mouse models of DMD. But the treatment has produced some off-target effects, which the researchers plan to investigate further in future studies. Friday, February 15, 2019 After casting off its Indian consumer health franchise, GlaxoSmithKline is selling its Chiron Behring Vaccines unit in India to Bharat Biotech. The transaction will create the world’s largest supplier of rabies vaccines. Wednesday, February 20, 2019 By delivering controlled electrical pulses to a portion of the brain linked to memory and alertness—and which forms part of a network involved in seizures—Medtronic aims to treat medication-resistant epilepsy patients using a deep brain stimulation implant similar to a cardiac pacemaker. Tuesday, February 19, 2019 The race is on between two Big Pharmas to snag a new indication in kidney cancer, but thanks to new data from Merck & Co., it may not matter who gets there first. Thursday, February 21, 2019 WuXi AppTec’s CDMO subsidiary STA Pharmaceutical has signed an exclusive tech and marketing deal with Swiss biotech BioLingus for sublingual delivery of drugs. Resources Sponsored by: Blue Matter White paper outlining the key types of cell-based immunotherapies in oncology, as well as the development and commercial outlook for each. Sponsored by: AlphaSense It’s never been more challenging to stay on top of trends and innovation shaping the future of healthcare. Discover how AI can help competitive intelligence teams achieve more proactive strategies. Sponsored by: Patheon, part of Thermo Fisher Scientific When a biologics company prepares to launch a new product, it must forecast the manufacturing capacity it will need, factoring in its estimate of the size of future sales, the timing of the launch, the dosage of the product, its strategy for building its market and a host of other variables. Sponsored by: Oracle Health Sciences 92% of survey respondents make changes to their RTSM/IRT systems due to study changes. See what else puts a strain on their clinical trials. Download the Research Whitepaper. Sponsored by: Patheon, part of Thermo Fisher Scientific Download this whitepaper to learn more. Sponsored by: The Kinetix Group Explore how the pharma industry can adapt its approach to the changing healthcare marketplace in the era of the Quadruple Aim Sponsored by: Cofactor Genomics Learn how Health Expression Models provide increased sensitivity, specificity, and accuracy for characterizing immune response in solid tumor specimens. Sponsored by: BioAnalytix, Inc. This whitepaper reviews fundamental aspects of HCPs that pertain to biologic drug development and presents current and emerging approaches to HCP analysis. Sponsored by: Veradigm Clinical trials take too long and cost too much—here's what needs to change. Sponsored by: Reprints Desk, Inc. Go from Search to Full-Text Scientific Papers in a Single Click! Sponsored by: Blue Latitude Health This white paper consists of original data and expert interviews. Download it today for exclusive tools, tips and analysis on achieving launch excellence in challenging pharma markets. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. | 